APA ציטוט

Zhu, P., Du, X. L., Lu, G., & Zhu, J. (2017). Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study. Oncotarget.

Citação norma Chicago

Zhu, Ping, Xianglin L. Du, Guangrong Lu, and Jay-Jiguang Zhu. "Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant With Radiation and Bevacizumab: A Population-based Study." Oncotarget 2017.

ציטוט MLA

Zhu, Ping, Xianglin L. Du, Guangrong Lu, and Jay-Jiguang Zhu. "Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant With Radiation and Bevacizumab: A Population-based Study." Oncotarget 2017.